Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.44 ◽

2021 ◽

Vol 5 (6) ◽

pp. s44

Author(s):

Linda Stein Gold ◽

Melinda Gooderham ◽

Kim Papp ◽

Laura Ferris ◽

Mark Lebwohl ◽

...

Keyword(s):

Plaque Psoriasis ◽

Adult Patients ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

N/A

Download Full-text

A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.012 ◽

2004 ◽

Vol 50 (3) ◽

pp. P2 ◽

Author(s):

Alan Menter ◽

Deborah Lew-Kaya ◽

Frederick Beddingfield ◽

Patricia S. Walker

Keyword(s):

Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Download Full-text

Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.17113 ◽

2021 ◽

Author(s):

M.G. Lebwohl ◽

L. Stein Gold ◽

K. Papp ◽

G. Han ◽

D.M. Pariser ◽

...

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Download Full-text

Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial

Dermatology and Therapy ◽

10.1007/s13555-021-00490-3 ◽

2021 ◽

Author(s):

Kim A. Papp ◽

Saskia de Vente ◽

Jiewei Zeng ◽

Mary Flack ◽

Byron Padilla ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase 2 ◽

Chronic Plaque Psoriasis ◽

Safety And Efficacy ◽

Open Label Extension ◽

Extension Trial

Download Full-text

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.859 ◽

2003 ◽

Vol 18 (6) ◽

pp. 549-551 ◽

Author(s):

V. P. Prasher ◽

C. Adams ◽

R. Holder ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Safety and Efficacy of 10 kHz Spinal Cord Stimulation for the Treatment of Refractory Chronic Migraine: A Prospective Long‐Term Open‐Label Study

Neuromodulation Technology at the Neural Interface ◽

10.1111/ner.13465 ◽

2021 ◽

Author(s):

Adnan Al‐Kaisy ◽

Stefano Palmisani ◽

Roy Carganillo ◽

Samuel Wesley ◽

David Pang ◽

...

Keyword(s):

Spinal Cord ◽

Chronic Migraine ◽

Spinal Cord Stimulation ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Refractory Chronic Migraine

Download Full-text

Effectiveness of weekly azathioprine pulse in the treatment of chronic plaque psoriasis: an open-label study

Clinical and Experimental Dermatology ◽

10.1111/ced.12887 ◽

2016 ◽

Vol 41 (7) ◽

pp. 717-722 ◽

Author(s):

P. Verma ◽

K. K. Verma ◽

N. Khanna ◽

S. Gupta ◽

N. Bhari

Keyword(s):

Plaque Psoriasis ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Download Full-text

A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.07.048 ◽

2014 ◽

Vol 71 (6) ◽

pp. 1176-1182 ◽

Author(s):

Kenneth B. Gordon ◽

Craig L. Leonardi ◽

Mark Lebwohl ◽

Andrew Blauvelt ◽

Gregory S. Cameron ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Interleukin 17A

Download Full-text

Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v66n0304 ◽

2005 ◽

Vol 66 (03) ◽

pp. 294-299 ◽

Author(s):

Lenard A. Adler ◽

Thomas J. Spencer ◽

Denái R. Milton ◽

Rodney J. Moore ◽

David Michelson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Hyperactivity Disorder

Download Full-text

Long-term Safety and Efficacy of Vigabatrin in Japanese Patients with Infantile Spasms: A Multicenter Open-label Study

Journal of the Japan Epilepsy Society ◽

10.3805/jjes.36.17 ◽

2018 ◽

Vol 36 (1) ◽

pp. 17-31 ◽

Author(s):

Yoko Ohtsuka ◽

Masayuki Horiguchi

Keyword(s):

Japanese Patients ◽

Infantile Spasms ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Open‐Label Study of Long‐Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann‐Pick Disease Type C

Case Medical Research ◽

10.31525/ct1-nct03893071 ◽

2019 ◽

Author(s):

Keyword(s):

Disease Type ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Niemann Pick Disease ◽

Type C ◽

Niemann Pick ◽

Download Full-text